
Modern cancer therapy produces substantial acute and chronic toxicity which zzso quality of life and limits the effectiveness of zzso Recent clinical and laboratory data suggest that repair of zzso injury is a zzso and continuous process providing multiple opportunities for zzso zzso A host of agents zzso zzso are under development that zzso normal tissue response or interfere with mechanisms of zzso Although significant challenges remain, the routine application of such agents promises to substantially reduce treatment related morbidity and potentially allow treatment zzso in high-risk zzso 

